NCT05248789View on ClinicalTrials.gov

OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

October 28, 2024

Study Completion Date

October 28, 2024

Conditions
Advanced Bladder Carcinoma
Interventions
BIOLOGICAL

OH2 injection

OH2: Oncolytic Type 2 Herpes Simplex Virus

Trial Locations (1)

430000

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan

Sponsors
All Listed Sponsors
lead

Binhui Biopharmaceutical Co., Ltd.

INDUSTRY